When Should You Have a PET-CT — After Radiotherapy?

You can raise it with your oncologist, and they will take your anxiety seriously. But an early scan often creates more anxiety, not less — because what it shows may be impossible to interpret correctly at that point. A suspicious area that turns out to be inflammation can feel just as frightening as one that turns out to be cancer, and your team may not be able to tell the difference without waiting anyway. The 12-week guideline exists to give you a result that is actually useful, not to make you wait for the sake of it.

A false-positive is when the scan shows an area of concern that is not actually cancer — in this context, usually because radiation-related inflammation is producing the same kind of signal that cancer cells would. It can lead to unnecessary worry, unnecessary biopsies, and sometimes unnecessary changes to your treatment plan. Waiting until the inflammation has settled reduces the chance of this happening. If a false-positive result has already been raised on your scan, ask your oncologist whether waiting and repeating the scan is an option before acting on it.

Twelve weeks is the most commonly cited figure in guidance from NCCN and ESMO, but your oncologist may recommend a different interval depending on your cancer type, where the radiation was given, and what decision the scan is informing. For some head and neck cancers, guidelines specifically recommend waiting at least this long. For other situations, the timing is adjusted based on clinical judgement. Ask your team what interval they are working to and why — the answer will be specific to your situation rather than a general rule.

Ten weeks falls within a range that some oncologists use, particularly when there is a clinical reason not to wait the full 12 weeks. Your oncologist will be aware that some inflammation may still be present and will read the result with that in mind. If you are unsure why 10 weeks was chosen rather than 12, ask — understanding the reason helps you engage with the result when it comes back.

A PET-CT does use a small radioactive tracer and X-ray, and your team factors this into their decision about when and how often to scan. The dose is considered acceptable when the scan is clinically indicated. It is a different kind of radiation from radiotherapy and is not added to the site being treated. If you have concerns about cumulative exposure, raise them with your oncologist — they can explain what the scan involves and why they feel the timing is appropriate for you.

They will look at where the uptake is, how intense it is, and how it compares with your baseline scan before treatment. They will also consider your symptoms and clinical examination. In many cases they can give a confident interpretation, but in some cases the scan is genuinely ambiguous — and the honest answer is that a biopsy is the only way to be certain. A scan that cannot give a clear answer is not a failed scan; it is a signal that the next step is a tissue sample rather than a treatment decision made on imaging alone.